Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap

British Journal of Pharmacology

Volumn 162, Issue 7, 2011, Pages 1577-1589

  Bazou, D ^a   Santos Martinez, M J ^a,b   Medina, C ^a   Radomski, M W ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

aggregation; disruption; platelets; suspension; tumour; ultrasound

Indexed keywords

1,10 PHENANTHROLINE; ACETYLSALICYLIC ACID; APYRASE; DUAL SPECIFICITY PHOSPHATASE 2; EDETIC ACID; EGTAZIC ACID; F ACTIN; GELATINASE A; PADGEM PROTEIN; PROSTACYCLIN;

ADENOCARCINOMA; ARTICLE; CELL ACTIVATION; CELL GROWTH; CELL STRUCTURE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; ENZYME RELEASE; EPIFLUORESCENCE MICROSCOPY; FIBROSARCOMA; FLOW CYTOMETRY; FLOW MEASUREMENT; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMAGE ANALYSIS; METASTASIS POTENTIAL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SCANNING ELECTRON MICROSCOPY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TUMOR CELL; ULTRASOUND; ULTRASOUND STANDING WAVE TRAP; ZYMOGRAPHY;

ACTINS; ADENOCARCINOMA; APYRASE; BLOOD PLATELETS; CELL COMMUNICATION; CELL LINE, TUMOR; DOWN-REGULATION; EDETIC ACID; EPOPROSTENOL; FEMALE; FIBROSARCOMA; FLOW CYTOMETRY; HUMANS; MATRIX METALLOPROTEINASE 2; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; OVARIAN NEOPLASMS; P-SELECTIN; PHENANTHROLINES; PLATELET ACTIVATION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; TUMOR CELLS, CULTURED; ULTRASONICS;

EID: 79952374005     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01182.x     Document Type: Article

References (53)

1. Alonso-Escolano D, Strongin AY, Chung AW, Deryugina EI, Radomski MW, (2004). Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins. Br J Pharmacol 141: 241-252. (Pubitemid 38250894)
2. Angiolillo DJ, Ueno M, Goto S, (2010). Basic principles of platelet biology and clinical implications. Circ J 74: 597-607.
3. Bazou D, Kuznetsova LA, Coakley WT, (2005a). Physical environment of 2-D animal cell aggregates formed in a short pathlength ultrasound standing wave trap. Ultrasound Med Biol 31: 423-430. (Pubitemid 40327231)
4. Bazou D, Foster GA, Ralphs JR, Coakley WT, (2005b). Molecular adhesion development in a neural cell monolayer forming in an ultrasound trap. Mol Membr Biol 22: 229-230.
5. Bazou D, Dowthwaite GP, Khan IM, Archer CW, Ralphs JR, Coakley WT, (2006). Gap junctional intercellular communication and cytoskeletal organization in chondrocytes in suspension in an ultrasound trap. Mol Membr Biol 23: 195-205. (Pubitemid 43786021)
6. Borsig L, (2008). The role of platelet activation in tumour metastasis. Expert Rev Anticancer Ther 8: 1247-1255.
7. Borsig L, Wong R, Feramisco J, Nadeau DR, Varki NM, Varki A, (2001). Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumour metastasis. Proc Natl Acad Sci USA 98: 3352-3357. (Pubitemid 32220849)
8. Bradberry S, Vale A, (2009). A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning. Clin Toxicol (Phila) 47: 841-848.
9. Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR, (2004). Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104: 397-401. (Pubitemid 38900020)
10. Carr ME Jr, Angchaisuksiri P, Carr SL, Martin EJ, (2003). Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood. Cell Biochem Biophys 39: 89-89.
11. 3. J Thromb Haemost 6: 517-523.
12. Diaz-Ricart M, Brunso L, Pino M, Navalon F, Jou JM, Heras M, et al. (2010). Preanalytical treatment of EDTA-anticoagulated blood to ensure stabilisation of the mean platelet volume and component measured with the ADVIA counters. Thromb Res 126: e30-e35.
13. Erpenbeck L, Schön MP, (2010). Deadly allies: the fatal interplay between platelets and metastasizing cancer cells. Blood 115: 3427-3486.
14. Fernandez-Patron C, Martinez-Cuesta MA, Salas E, Sawicki G, Wosniak M, Radomski MW, et al. (1999). Differential regulation of platelet aggregation by matrix metalloproteinases-9 and -2. Thromb Haemost 82: 1730-1735.
15. Gfeller KY, Nugaeva N, Hegner M, (2005). Rapid biosensor for detection of antibiotic-selective growth of Escherichia coli. Appl Environ Microbiol 71: 2626-2231.
16. Heyns AP, Eldor A, Yarom R, Marx G, (1985). Zinc-induced platelet aggregation is mediated by the fibrinogen receptor and is not accompanied by the release or by thromboxane synthesis. Blood 66: 213-219. (Pubitemid 15004806)
17. Honn KV, Tang DG, Crissman JD, (1992). Platelets and cancer metastasis: a causal relationship? Cancer Metastasis Rev 11: 325-331.
18. Ho-Tin-Noé B, George T, Cifuni SM, Duerschmied D, Wagner DD, (2008). Platelet granule secretion continuously prevents intratumour hemorrhage. Cancer Res 68: 6851-6858.
19. Ho-Tin-Noé B, Goerge T, Wagner DD, (2009). Platelets: guardians of tumour vasculature. Cancer Res 69: 5623-5626.
20. Jennings LK, (2009). Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 102: 248-257.
21. Jurasz P, Stewart MW, Radomski A, Khadour F, Duszyk M, Radomski MW, (2001a). Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin. Br J Pharmacol 134: 1104-1112. (Pubitemid 33052170)
22. Jurasz P, Sawicki G, Duszyk M, Sawicka J, Miranda C, Mayers I, et al. (2001b). Matrix metalloproteinase 2 in tumour cell-induced platelet aggregation: regulation by nitric oxide. Cancer Res 61: 376-382. (Pubitemid 32095741)
23. Jurasz P, North S, Venner P, Radomski MW, (2003). Matrix metalloproteinase-2 contributes to increased platelet reactivity in patients with metastatic prostate cancer: a preliminary study. Thromb Res 112: 59-64. (Pubitemid 38167587)
24. Jurasz P, Alonso-Escolano D, Radomski MW, (2004). Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol 143: 819-826. (Pubitemid 39664840)
25. Jurk K, Kehrel BE, (2005). Platelets: physiology and biochemistry. Semin Thromb Hemost 31: 381-392. (Pubitemid 41362342)
26. Khorana AA, Fine RL, (2004). Pancreatic cancer and thromboembolic disease. Lancet Oncol 5: 655-663. (Pubitemid 40267849)
27. Kim YJ, Borsig L, Varki NM, Varki A, (1998). P-selectin deficiency attenuates tumour growth and metastasis. Proc Natl Acad Sci USA 95: 9325-9330. (Pubitemid 28506230)
28. Kurtoglou E, Ugur A, Baltaci AK, Helifeoglou I, (2004). Effects of trace element levels on platelet aggregation. Biol Trace Elem Res 99: 93-98. (Pubitemid 38969000)
29. Läubli H, Borsig L, (2010). Selectins promote tumour metastasis. Semin Cancer Biol 20: 167-177.
30. Lim MC, Lee HS, Kang S, Seo S-S, Lee BY, Park S-Y, (2010). Minimizing tumor burden by extensive cytoreductive surgery decreases postoperative venous thromboembolism in ovarian clear cell carcinoma. Arch Gynecol Obstet 281: 329-334.
31. Linenberger ML, Wittkovsky AK, (2005). Thromboembolic complications of malignancy. Part 1: risks. Oncology 19: 853-861. (Pubitemid 41725380)
32. Liu Y, Zhao F, Gu W, Yang H, Meng Q, Zhang Y, et al. (2009). The roles of platelet GPIIb/IIIa and alphavbeta3 integrins during HeLa cells adhesion, migration, and invasion to monolayer endothelium under static and dynamic shear flow. J Biomed Biotechnol 2009: 829243.
33. Malik AB, Selig WM, Burhop KE, (1985). Cellular and humoral mediators of pulmonary edema. Lung 163: 193-199.
34. Martinez A, Salas E, Radomski A, Radomski MW, (2001). Matrix metalloproteinase-2 in platelet adhesion to fibrinogen: interactions with nitric oxide. Med Sci Monit 7: 646-651. (Pubitemid 32691741)
35. Medina C, Jurasz P, Santos-Matrinez MJ, Jeong SS, Mitsky T, Chen R, et al. (2006). Platelet aggregation-induced by Caco-2 cells: regulation by matrix metalloproteinase-2 and adenosine diphosphate. J Pharmacol Exp Ther 317: 739-745.
36. Moncada S, Grygliewski R, Bunting S, Vane JR, (1976). An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature 263: 663-665.
37. Nierodzik ML, Karpatkin S, (2006). Thrombin induces tumour growth, metastasis, and angiogenesis: evidence for a thrombin-regulated dormant tumour phenotype. Cancer Cell 10: 355-362. (Pubitemid 44693468)
38. Palumbo JS, Talmage KE, Massari JV, La Jeunesse CM, Flick MJ, Kombrinck KW, et al. (2005). Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumour cells. Blood 105: 178-185. (Pubitemid 40053080)
39. Philippe C, Philippe B, Fouqueray B, Perez J, Lebret M, Baud L, (1993). Protection from tumour necrosis-factor-mediated cytolysis by platelets. Am J Pathol 143: 1713-1723. (Pubitemid 24058274)
40. Radomski M, Moncada S, (1983). An improved method for washing of human platelets with prostacyclin. Thromb Res 30: 383-389. (Pubitemid 13053477)
41. Radomski A, Jurasz P, Alsonso-Escolano D, Drews M, Morandi M, Malinski T, et al. (2005). Nanoparticle-induced platelet aggregation and cascular thrombosis. Br J Pharmacol 146: 882-893. (Pubitemid 41622255)
42. Sacchetti G, Gibelli A, Bellani D, Montanari C, (1973). Effect of manganese ions on human platelet aggregation in vitro. Experientia 30: 374-375.
43. Santos-Martinez MJ, Medina C, Jurasz P, Radomski MW, (2008). Role of metalloproteinases in platelet function. Thromb Res 121: 535-542. (Pubitemid 351174273)
44. Sawicki G, Salas E, Murat J, Miszta-Lane H, Radomski MW, (1997). Release of gelatinase A during platelet activation mediates aggregation. Nature 386: 616-629.
45. Sørensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL, (1998). The risk of diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338: 1169-1173. (Pubitemid 28180744)
46. Trousseau A, (1865). Phlegmatia Alba Dolens, Vol. 3. JB Baillere et Fils: Paris, pp. 654-662.
47. Troxler K, Dickinson K, Homer-Vanniasinkam S, (2007). Platelet function and antiplatelet therapy. Br J Surg 94: 674-682. (Pubitemid 46910058)
48. Varga-Szabo D, Pleines I, Nieswandt B, (2008). Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 28: 403-412.
49. Von Tempelhoff G-F, Niemann F, Schneider DM, (1998). Blood rheology during chemotherapy in patients with ovarian cancer. Thromb Res 90: 73-82. (Pubitemid 28348292)
50. Wahrenbrock M, Borsig L, Le D, Varki N, Varki A, (2003). Selectin-Mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest 112: 853-862. (Pubitemid 38063743)
51. Wang JS, Chang CY, Chow SE, Chen YW, Yang CM, (2007). Exercise modulates platelet-nasopharyngeal carcinoma cell aggregation and subsequent tissue factor and matrix metalloproteinase activities. J Appl Physiol 103: 763-770.
52. White JG, Krumwiede MD, Escolar G, (1999). EDTA induced changes in platelet structure and function: influence on particle uptake. Platelets 10: 327-337. (Pubitemid 29490860)
53. Winter PC, (2006). The pathogenesis of venous thromboembolism in cancer: emerging links with tumour biology. Hematol Oncol 24: 126-133. (Pubitemid 44483905)